港股异动 | 荃信生物-B(02509)涨超10% 拟重续QX001S框架协议年度上限 公司自免双抗价值持续兑现
Last Update:
13 11 月, 2025
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.